A group of individuals in rural Wyoming made it their mission to increase access to care for the medically underserved by creating a Federally-qualified Health Center.
Watch Dr. Fauci, Director of the National Institute of Health’s Institute of Allergy and Infectious Diseases (NIAID), describe the exciting and significant findings from the START Study: HIV therapy should begin immediately!
Electronic cigarettes (ENDS) are growing in popularity, as well as the public misconceptions around their health-risks. Learn more about these popular e-cigarettes, especially among young adults, and how local RI providers are educating people about the serious health issues related to ENDS.
Males are half the equation when we’re talking about teen pregnancy prevention. In honor of National Teen Pregnancy Prevention Month, JSI’s Myriam Hernandez-Jennings explains the importance of bringing young men into the conversation about family planning, pregnancy prevention, and healthy relationships.
Design thinking takes a human-centered approach to creating and implementing innovative programs, integrating the needs of the people/customers, the possibilities of technology and other innovations, and the requirements of business success. The design process starts with empathy generation, and then moves through various stages until you’re testing a final prototype with users.
Pediatric asthma affects an estimated 7.1 million children in the U.S. under the age of 18. In the city of Lawrence, Massachusetts, a largely immigrant Latino community, pediatric asthma affects more than 14% of school age children, primarily due to environmentally related health disparities. In a city like Lawrence, issues such as language, literacy, and culture present challenges to reaching and engaging families in environmental health education.
This poses a serious question for all of us working in HIV/AIDS-related projects across African countries. It is rare to find a clear policy on professional PEP, and even when policy is in place, its implementation is patchy to say the least. Health workers in program-supported facilities get exposed to possible infection, but data are scanty (no directory of professional incidents is being compiled); ARVs may not be easily available for any use other than treating registered patients; and a sense of resignation about the occurrence of these incidents is common among health staff. While the PEP strategy is being gradually expanded for post-rape survivors, it is paramount to provide it for health workers even in remote facilities with no ARV provision.
our programs should nonetheless endeavor to gather as much data on other aspects of care as possible and to find time for elaborating and analyzing more health information. This could produce two essential results. First, by doing so we should be able to look at the broader picture of our intervention as far as health care services are concerned. Secondly, we could be more informed and authoritative in documenting our findings, supporting our views, and contributing to the design of future programs.
Continuing the conversation about more effective use of the newer medications to improve efficacy and decrease toxicity in HIV patients.
The IAS-USA Treatment Guidelines were released during the conference, supporting earlier initiation of treatment with ART recommended for all patients with CD4 counts < 500, selected clinical conditions, and all symptomatic patients (provided patients are ready to start therapy: “The patient must be ready and willing to adhere to lifelong therapy,” the document explicitly states. Additional populations for ART initiation included pregnant women, and those with acute primary infections. The document is well worth a good read for its careful review of the data behind the pendulum swinging to earlier initiation in 2010.